- Filed
- Nov 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 6, 2025 | 18.15M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 17.78K sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 14.23K sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 3.48K sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 3.45K sh |
| Capex | Q3 2025 · Sep 30, 2025 | $575K |
| Capex | Q3 2025 · Sep 30, 2024 | $869K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$36.81M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$99.82M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $95.52M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $197.38M |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $142.2M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $34.67M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $36.44M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $124.01M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $142.37M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $154.78M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $169.87M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $26.82M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $47.82M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $68.6M |
| Stockholders Equity | Q3 2025 · Mar 31, 2024 | $93.2M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $122.89M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $37.45M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $45.38M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $134.89M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $248.98M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $265.37M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $258.22M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $277.26M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $275.8M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$1.00 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$4.37 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$8.02 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$29.71 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$1.00 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$4.37 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$8.02 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$29.71 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $8.48M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $25.94M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $10.1M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $34.23M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $5.38M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $16.18M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $8.14M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $30.51M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$17.84M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$62.16M |
| Net Income | Q3 2025 · Jun 30, 2025 | −$18.54M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$25.78M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$27.94M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$102.34M |
| Net Income | Q3 2025 · Jun 30, 2024 | −$34.45M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$39.94M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$15.81M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$49.08M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$23.84M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$91.52M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $11.59M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $34.52M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $9.82M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $27.82M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $17.84M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $56.08M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $18.85M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $56.41M |
| Revenue | Q3 2025 · Sep 30, 2025 | $29.43M |
| Revenue | Q3 2025 · Sep 30, 2025 | $90.6M |
| Revenue | Q3 2025 · Sep 30, 2024 | $28.67M |
| Revenue | Q3 2025 · Sep 30, 2024 | $84.22M |